Pillar
AI Inside Commercial Operations
Where AI fits in how marketing teams actually run. Not theoretical. From the Novartis framework that embedded AI into 50% of marketing operations across 4 therapeutic areas and 10 brands.
-
The Real Reason Your Commercial Team Won't Embrace AI
Most commercial teams have stopped arguing about whether AI belongs inside the work. That fight is over. Nobody I talk to defends the idea that AI is a productivity add-on bolted onto the side of the real process anymore.
-
Combination Product Commercialization: Why the Data Architecture Decision Cannot Wait for Clearance
For a connected device, the customer, the data, and the trust are commercial decisions. Make them before clearance, or they get made for you.
-
You Measure Molecules This Way. Your AI Deserves the Same.
Pharma measures every molecule against a control. Almost no AI gets the same. Six systems here do.
-
AI Is Not a Tool. It Is an Operating Layer.
Most pharma teams are using AI. Fewer have made it part of how their commercial operation actually runs. That distinction is structural, not philosophical. Here is what it looked like when I built it at Novartis.
-
Commercial Execution Is What Turns Science Into Investment
Innovation in healthcare does not begin with a scientific breakthrough. It begins with trust. And trust is built through commercial execution, brand by brand, customer by customer, quarter by quarter. I spent 25 years building commercial operations at Roche, Sanofi,
-
A Unified Commercial Story Outperforms Any Channel Mix
Most pharma and MedTech teams have invested in omnichannel. They have the channels. What they often do not have is a single story running through all of them. That distinction cost real brand performance. At Novartis, I built a global